Carmen Volovăţ

476 total citations
9 papers, 348 citations indexed

About

Carmen Volovăţ is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Carmen Volovăţ has authored 9 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Pharmacology. Recurrent topics in Carmen Volovăţ's work include Renal Diseases and Glomerulopathies (4 papers), Vasculitis and related conditions (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Carmen Volovăţ is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Vasculitis and related conditions (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Carmen Volovăţ collaborates with scholars based in Romania and United Kingdom. Carmen Volovăţ's co-authors include Adrian Covic, Paul Gusbeth–Tatomir, Irina-Draga Căruntu, Liviu Segall, Cristina Gluhovschi, Adalbert Schiller, Silvia Velciov, Flaviu Bob, Claudiu Stoicescu and Gheorghe Gluhovschi and has published in prestigious journals such as Nephrology Dialysis Transplantation, Liver International and BMC Nephrology.

In The Last Decade

Carmen Volovăţ

9 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Volovăţ Romania 6 177 86 68 63 57 9 348
J Donck Belgium 10 57 0.3× 107 1.2× 44 0.6× 109 1.7× 24 0.4× 23 650
F. Villemain France 8 93 0.5× 43 0.5× 42 0.6× 127 2.0× 27 0.5× 13 757
Brian Radbill United States 10 97 0.5× 48 0.6× 80 1.2× 98 1.6× 21 0.4× 12 426
Neumayer Hh Germany 12 64 0.4× 47 0.5× 36 0.5× 47 0.7× 13 0.2× 38 468
Thomas Vanhove Belgium 13 82 0.5× 43 0.5× 42 0.6× 91 1.4× 60 1.1× 24 678
João Victor Salgado Brazil 11 134 0.8× 52 0.6× 19 0.3× 82 1.3× 16 0.3× 27 393
Ching-Wei Tsai Taiwan 10 256 1.4× 68 0.8× 18 0.3× 87 1.4× 16 0.3× 17 644
Jean Stenstrøm Norway 8 103 0.6× 120 1.4× 41 0.6× 33 0.5× 8 0.1× 10 441
David Metz United States 11 88 0.5× 30 0.3× 44 0.6× 70 1.1× 11 0.2× 19 360
Eyüp Külah Türkiye 12 141 0.8× 64 0.7× 38 0.6× 56 0.9× 9 0.2× 27 365

Countries citing papers authored by Carmen Volovăţ

Since Specialization
Citations

This map shows the geographic impact of Carmen Volovăţ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Volovăţ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Volovăţ more than expected).

Fields of papers citing papers by Carmen Volovăţ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Volovăţ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Volovăţ. The network helps show where Carmen Volovăţ may publish in the future.

Co-authorship network of co-authors of Carmen Volovăţ

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Volovăţ. A scholar is included among the top collaborators of Carmen Volovăţ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Volovăţ. Carmen Volovăţ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Voroneanu, Luminița, Dimitrie Siriopol, Ionuţ Nistor, et al.. (2019). Evaluation of low-dose glucocorticoid regimen in association with cyclophosphamide in patients with glomerulonephritis. International Urology and Nephrology. 51(10). 1805–1813. 5 indexed citations
2.
Siriopol, Dimitrie, Simona Hogaş, Irina Mititiuc, et al.. (2014). Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis. International Urology and Nephrology. 47(3). 563–569. 33 indexed citations
3.
Volovăţ, Carmen, Irina-Draga Căruntu, Simona Ruxandra Volovăț, et al.. (2013). Changes in the histological spectrum of glomerular diseases in the past 16 years in the North-Eastern region of Romania. BMC Nephrology. 14(1). 148–148. 14 indexed citations
4.
Gusbeth–Tatomir, Paul, et al.. (2007). [Epidemiology of biopsy-proven renal disease in Romania: data from a regional registry in north-eastern Romania].. PubMed. 110(3). 540–7. 3 indexed citations
5.
Covic, Adrian, Nicoleta Mardare, Florentina Ioniţă‐Radu, et al.. (2006). Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit. Journal of Nephrology. 19(6). 794–801. 48 indexed citations
6.
Covic, Adrian, Adalbert Schiller, Carmen Volovăţ, et al.. (2005). Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrology Dialysis Transplantation. 21(2). 419–424. 125 indexed citations
8.
Covic, Adrian, et al.. (2001). Should CAPD be the first choice for dialysis in Romania? Audit of the Iasi ‘C. I. Parhon’ Dialysis Center: 1995–2000. Nephrology Dialysis Transplantation. 16(10). 1996–2001. 4 indexed citations
9.
Covic, Adrian, et al.. (1998). Rifampicin-induced acute renal failure: a series of 60 patients. Nephrology Dialysis Transplantation. 13(4). 924–929. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026